JP2020530846A5 - - Google Patents

Download PDF

Info

Publication number
JP2020530846A5
JP2020530846A5 JP2020508317A JP2020508317A JP2020530846A5 JP 2020530846 A5 JP2020530846 A5 JP 2020530846A5 JP 2020508317 A JP2020508317 A JP 2020508317A JP 2020508317 A JP2020508317 A JP 2020508317A JP 2020530846 A5 JP2020530846 A5 JP 2020530846A5
Authority
JP
Japan
Prior art keywords
peptide
subject
myelin
disease
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020508317A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020530846A (ja
JP7419229B2 (ja
Filing date
Publication date
Priority claimed from GBGB1713035.2A external-priority patent/GB201713035D0/en
Priority claimed from GBGB1713037.8A external-priority patent/GB201713037D0/en
Priority claimed from GBGB1713036.0A external-priority patent/GB201713036D0/en
Application filed filed Critical
Priority claimed from PCT/GB2018/052304 external-priority patent/WO2019034862A1/en
Publication of JP2020530846A publication Critical patent/JP2020530846A/ja
Publication of JP2020530846A5 publication Critical patent/JP2020530846A5/ja
Application granted granted Critical
Publication of JP7419229B2 publication Critical patent/JP7419229B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020508317A 2017-08-14 2018-08-14 方法 Active JP7419229B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB1713036.0 2017-08-14
GBGB1713035.2A GB201713035D0 (en) 2017-08-14 2017-08-14 Method
GB1713037.8 2017-08-14
GB1713035.2 2017-08-14
GBGB1713037.8A GB201713037D0 (en) 2017-08-14 2017-08-14 Method
GBGB1713036.0A GB201713036D0 (en) 2017-08-14 2017-08-14 Method
PCT/GB2018/052304 WO2019034862A1 (en) 2017-08-14 2018-08-14 Method

Publications (3)

Publication Number Publication Date
JP2020530846A JP2020530846A (ja) 2020-10-29
JP2020530846A5 true JP2020530846A5 (https=) 2021-09-24
JP7419229B2 JP7419229B2 (ja) 2024-01-22

Family

ID=63294371

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020508317A Active JP7419229B2 (ja) 2017-08-14 2018-08-14 方法

Country Status (8)

Country Link
US (1) US20210093695A1 (https=)
EP (1) EP3668535A1 (https=)
JP (1) JP7419229B2 (https=)
CN (1) CN111225681A (https=)
AU (2) AU2018316662A1 (https=)
CA (1) CA3072867A1 (https=)
WO (1) WO2019034862A1 (https=)
ZA (1) ZA202000882B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111983241B (zh) * 2020-09-04 2022-05-20 四川大学华西医院 诊断脑卒中认知障碍的蛋白标志物以及模型的训练方法
WO2023100758A1 (ja) * 2021-11-30 2023-06-08 国立大学法人京都大学 ペプチド含有組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020072493A1 (en) * 1998-05-19 2002-06-13 Yeda Research And Development Co. Ltd. Activated T cells, nervous system-specific antigens and their uses
AU2008320657B2 (en) * 2007-10-31 2013-09-05 Worg Pharmaceuticals (Zhejiang) Co., Ltd. Composition
GB201300684D0 (en) * 2013-01-15 2013-02-27 Apitope Int Nv Peptide
GB201300683D0 (en) * 2013-01-15 2013-02-27 Apitope Int Nv Peptide
US10759838B2 (en) * 2015-03-09 2020-09-01 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use

Similar Documents

Publication Publication Date Title
JP2017158561A5 (https=)
JP2019196370A5 (https=)
JOP20220316A1 (ar) لقاح متعدد الحاتمات لمعالجة مرض الزهايمر
RU2013139651A (ru) Новые соединения, влияющие на пищевое поведение
MX377262B (es) Compuesto derivado de amida de 1,3,4-oxadiazol como inhibidor de histona desacetilasa 6 y composición farmacéutica que lo contiene.
JP2016535786A5 (https=)
JPWO2019156137A5 (https=)
JP2006506942A5 (https=)
RU2017128296A (ru) Композиция для лечения бесплодия
BR112021017203A2 (pt) Leucina, acetil leucina e análogos relacionados para o tratamento de doenças
EA202193190A1 (ru) Композиция, включающая придопидин и его аналог, для лечения болезни гентингтона и ее симптомов
JP2020530846A5 (https=)
CA3168125A1 (en) Methods of treatment of asthma and copd
RU2017121836A (ru) Нейродегенеративные расстройства
WO2020219486A3 (en) Collagen peptide-based medicament compositions and devices and methods of production and use thereof
IL308132A (en) Methods of treatment of autoimmune disorders using ilt7 binding proteins
BR112022009898A2 (pt) Composições e métodos para desrepressão de genes alvo do fator de transcrição silenciador de re1
RU2015134357A (ru) Пептид
JP2016528171A5 (https=)
RU2015134356A (ru) Пептид
JP2016539911A5 (https=)
EA202192160A1 (ru) Доставка полинуклеотида cln3 с помощью аденоассоциированного вируса
JP2009542609A5 (https=)
JP2019512507A5 (https=)
EA202190724A1 (ru) Препарат на основе кетамина для лечения депрессий путём ингаляций